Pasithea Therapeutics Corp. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE8-KPasithea Therapeutics Corp.KTTAWSep 16

   Current report

2. NOTABLE25-NSEPasithea Therapeutics Corp.KTTAWSep 16

   Delisting notice

   Nasdaq Stock Market LLC, filed by

3. ROUTINE8-KPasithea Therapeutics Corp.KTTAWSep 9

   Current report

4. ROUTINE8-KPasithea Therapeutics Corp.KTTAWAug 21

   Current report

5. NOTABLE10-QPasithea Therapeutics Corp.KTTAWAug 14

   Quarterly report

6. ROUTINESCHEDULE 13G/APasithea Therapeutics Corp.KTTAWAug 14

   Ownership stake disclosure by Vivo Opportunity Fund Holdings, L.P. (amended)

   Vivo Opportunity Fund Holdings, L.P., filed by

7. ROUTINEARSPasithea Therapeutics Corp.KTTAWAug 7

   Annual report to shareholders

8. ROUTINEDEF 14APasithea Therapeutics Corp.KTTAWAug 7

   Proxy statement

9. ROUTINESCHEDULE 13G/APasithea Therapeutics Corp.KTTAWJul 31

   Ownership stake disclosure by Opaleye Management Inc. (amended)

   Opaleye Management Inc., filed by

10. ROUTINEPRE 14APasithea Therapeutics Corp.KTTAWJul 29

    Preliminary proxy statement

11. ROUTINESCHEDULE 13G/APasithea Therapeutics Corp.KTTAWJul 1

    Ownership stake disclosure by Coastlands Capital LP (amended)

    Coastlands Capital LP, filed by

12. ROUTINESCHEDULE 13GPasithea Therapeutics Corp.KTTAWJun 23

    Ownership stake disclosure by Stonepine Capital Management, LLC

    Stonepine Capital Management, LLC, filed by

13. ROUTINE4Pasithea Therapeutics Corp.KTTAWJun 22

    Coastlands Capital LP, insider filing for KTTAW

    Coastlands Capital LP, reporting

14. NOTABLE10-QPasithea Therapeutics Corp.KTTAWMay 15

    Quarterly report

15. ROUTINESCHEDULE 13G/APasithea Therapeutics Corp.KTTAWMay 15

    Ownership stake disclosure by AMERIPRISE FINANCIAL INC (amended)

    AMERIPRISE FINANCIAL INC, filed by

16. ROUTINE4Pasithea Therapeutics Corp.KTTAWMay 5

    8 insider filings

    Tiago Marques, insider filing for KTTAW

    Show all 8

    • 4Insider filing for KTTAWMay 5
    • 4Insider filing for KTTAWMay 5
    • 4Insider filing for KTTAWMay 5
    • 4Insider filing for KTTAWMay 5
    • 4Insider filing for KTTAWMay 5
    • 4Insider filing for KTTAWMay 5
    • 4Insider filing for KTTAWMay 5
    • 3New insider at KTTAWMay 5

    Tiago Marques, reporting

17. ROUTINE8-KPasithea Therapeutics Corp.KTTAWMay 4

    Current report

18. ROUTINESCHEDULE 13GPasithea Therapeutics Corp.KTTAWApr 22

    Ownership stake disclosure by Funicular Funds, LP

    Funicular Funds, LP, filed by

19. ROUTINE3Pasithea Therapeutics Corp.KTTAWApr 17

    Coastlands Capital LP, new insider at KTTAW

    Coastlands Capital LP, reporting

20. ROUTINESCHEDULE 13GPasithea Therapeutics Corp.KTTAWApr 8

    Ownership stake disclosure by Opaleye Management Inc.

    Opaleye Management Inc., filed by

21. NOTABLE10-KPasithea Therapeutics Corp.KTTAWMar 30

    Annual report

22. ROUTINESCHEDULE 13GPasithea Therapeutics Corp.KTTAWFeb 27

    Ownership stake disclosure by Coastlands Capital LP

    Coastlands Capital LP, filed by

23. ROUTINE8-KPasithea Therapeutics Corp.KTTAWFeb 20

    Current report

24. ROUTINESCHEDULE 13G/APasithea Therapeutics Corp.KTTAWFeb 17

    Ownership stake disclosure by CVI Investments, Inc. (amended)

    CVI Investments, Inc., filed by

25. ROUTINESCHEDULE 13G/APasithea Therapeutics Corp.KTTAWFeb 17

    Ownership stake disclosure by Squadron Capital Management LLC (amended)

    Squadron Capital Management LLC, filed by

26. ROUTINESCHEDULE 13GPasithea Therapeutics Corp.KTTAWFeb 17

    Ownership stake disclosure by AMERIPRISE FINANCIAL INC

    AMERIPRISE FINANCIAL INC, filed by

27. ROUTINESCHEDULE 13GPasithea Therapeutics Corp.KTTAWFeb 12

    Ownership stake disclosure by Adage Capital Management, L.P.

    Adage Capital Management, L.P., filed by

28. ROUTINES-8Pasithea Therapeutics Corp.KTTAWJan 30

    Employee stock plan registration

29. ROUTINE8-KPasithea Therapeutics Corp.KTTAWJan 28

    Current report

30. ROUTINEEFFECTPasithea Therapeutics Corp.KTTAWJan 28

    Registration declared effective

31. ROUTINEPOS AMPasithea Therapeutics Corp.KTTAWJan 26

    POS AM filing

32. ROUTINEDEF 14APasithea Therapeutics Corp.KTTAWDec 29, 2025

    Proxy statement

33. ROUTINEPRE 14APasithea Therapeutics Corp.KTTAWDec 19, 2025

    Preliminary proxy statement

34. ROUTINE8-KPasithea Therapeutics Corp.KTTAWDec 15, 2025

    Current report

35. ROUTINESCHEDULE 13GPasithea Therapeutics Corp.KTTAWDec 8, 2025

    Ownership stake disclosure by JANUS HENDERSON GROUP PLC

    JANUS HENDERSON GROUP PLC, filed by

36. ROUTINESCHEDULE 13GPasithea Therapeutics Corp.KTTAWDec 5, 2025

    2 13G filings

    Ownership stake disclosure by Squadron Capital Management LLC

    Show all 2

    • SCHEDULE 13GOwnership stake disclosureDec 5, 2025
    • SCHEDULE 13GOwnership stake disclosureDec 5, 2025

    Squadron Capital Management LLC, filed by

37. ROUTINE8-KPasithea Therapeutics Corp.KTTAWDec 2, 2025

    Current report

38. ROUTINE4Pasithea Therapeutics Corp.KTTAWDec 1, 2025

    5 insider filings

    Lawrence Steinman, insider filing for KTTAW

    Show all 5

    • 4Insider filing for KTTAWDec 1, 2025
    • 4Insider filing for KTTAWDec 1, 2025
    • 4Insider filing for KTTAWDec 1, 2025
    • 4Insider filing for KTTAWDec 1, 2025
    • 4Insider filing for KTTAWDec 1, 2025

    Lawrence Steinman, reporting

Older filings on EDGAR